Rx Medicare

Researchers are developing a DNA-based vaccine against the dreaded West Nile virus (WNV), which can be transmitted from animals to humans. The unique feature of this vaccine is that it is also effective after onset of the disease, for it has therapeutic properties.

Read More…

Related Posts

• FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus
• Medical Imaging Identifies Severe Case Of H1N1 And May Help Researchers Understand The Pathogenesis Of The Virus
• Better Vaccine Procedure Sought By Rice Researchers
• Flu Virus Ill-Suited For Rapid Transmission, But Researchers Say New Strain Bears Watching, Could Mutate
• USC Researchers Uncover Mechanism That Allows Influenza Virus To Evade The Body¹s Immune Response
• Researchers Working On Faster Ways To Detect And Attack H1N1 Flu Virus
• FDA Researchers Contribute Insights Into Avian Flu Virus
• New Vaccine Developed For Preventing “Uncommon Cold” Virus
• Baxter Presents Clinical Efficacy Results From Phase III Study Of Seasonal Flu Vaccine
• AmpVacs A Broadly Protective Synthetic Influenza A Vaccine
• Diagnostic Hybrids Receives FDA Emergency Use Authorization For D3 Ultra 2009 H1N1 Influenza A Virus ID Kit
• Dynavax Selects Clinical Candidate In Universal Flu Vaccine Program
• Virus Hybridization Could Create Pandemic Bird Flu
• FDA Recommends H1N1 For Inclusion In Next Year’s Flu Vaccine
• PositiveID Corporation Successfully Completes Phase I Development Of Its Rapid Virus Detection System

Tags: develop, efficacy, nile, researchers, vaccine, virus, west

This entry was posted on Saturday, January 17th, 2009 at 1:01 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.